v3.26.1
Document and Entity Information
May 29, 2026
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date May 29, 2026
Entity File Number 001-730430
Entity Registrant Name Kiniksa Pharmaceuticals International, plc
Entity Incorporation, State or Country Code X0
Entity Tax Identification Number 98-1795578
Entity Address, Address Line One 105 Piccadilly, Second Floor
Entity Address, City or Town London
Entity Address, Postal Zip Code W1J 7NJ
Entity Address, Country GB
City Area Code 781
Local Phone Number 431-9100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Ordinary Shares $0.000273235 nominal value
Trading Symbol KNSA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001730430
Amendment Flag false